Delivery Order SPE2DB20D1004-SPE2DB25FNKFP
Award Date 8/19/25
Potential Completion Date 8/20/25
Potential Value $2.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $2,137.63 to AmerisourceBergen Drug Corp for 120 capsules of Jatenzo 237 mg, a testosterone replacement therapy medication. This non-set-aside, competitively awarded contract was issued on August 20, 2025, with an ultimate completion date of August 21, 2025, and operates under a firm fixed price arrangement. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order valued at $2,263.74 to AmerisourceBergen Drug Corp for 120 capsules of Jatenzo 237 mg on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Jatenzo is a testosterone replacement therapy medication used to treat hypogonadism in adult males,...
- The Defense Logistics Agency awarded a $1,131.87 delivery order to AmerisourceBergen Drug Corp for 120 capsules of Jantenzo 237 mg, a testosterone replacement therapy medication. This competitively awarded, firm fixed-price contract was executed on August 20, 2025, with an ultimate completion date of August 21, 2025. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,131.87 to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Jatenzo 237 mg capsules (120-count units). This is a firm fixed-price, non-set-aside contract with a completion date of August 8, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. Jatenzo is a testosterone replacement therapy indicated for hypogonadism treatment, reflecting the federal government's...
- The Defense Logistics Agency awarded a delivery order valued at $1,336.63 to AmerisourceBergen Drug Corp for 120 capsules of Jantenzo 237 mg, a testosterone replacement therapy medication. The award, issued on July 30, 2025, with an ultimate completion date of July 31, 2025, was made without set-aside designation through open competition using firm fixed price contracting. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Jatenzo 198 mg capsules (120-count units) valued at $1,131.88 under a firm fixed-price contract. This is a non-set-aside competitive award with an ultimate completion date of August 13, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,253.16 to AmerisourceBergen Drug Corp for 120 capsules of Jantenzo 198 mg, a testosterone replacement therapy medication. The contract was competitively awarded without set-aside designation on July 21, 2025, with an ultimate completion date of July 22, 2025. Performance will occur at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under firm fixed-price terms and...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Jatenzo 237 mg capsules (120 count), with a ceiling value of $2,479.28. This competitive delivery order, issued with firm fixed pricing, represents a non-set-aside award and is scheduled for ultimate completion by August 14, 2025. The pharmaceutical product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency awarded a delivery order valued at $3,425.67 to AmerisourceBergen Drug Corp for the supply of Jatenzo 237 mg capsules (120-count units) under a firm fixed-price contract type. The award was made on August 18, 2025, with an ultimate completion date of August 19, 2025. This is a non-set-aside contract, reflecting competitive procurement practices. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a $8,442.15 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Jatenzo 237 mg capsules (120-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of July 24, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, reflecting the company's role as a major pharmaceutical distributor serving federal...